首页> 外文期刊>Psychopharmacology >Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats
【24h】

Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats

机译:在大鼠进行高迷宫试验2期间,NMDA /甘氨酸B受体配体的抗焦虑作用消失了

获取原文
获取原文并翻译 | 示例
           

摘要

Drugs enhancing the GABAA and/or reducing the NMDA/glycine-B receptor activity produce an anxiolytic effect. Regarding the former drugs (e.g. benzodiazepines), prior elevated plus-maze (EPM) test experience abolishes the trial 2 anxiolytic activity, a phenomenon referred to as "one-trial tolerance" (OTT).
机译:增强GABAA 和/或降低NMDA /甘氨酸B受体活性的药物可产生抗焦虑作用。对于以前的药物(例如苯二氮卓类药物),先前的高迷宫试验(EPM)取消了试验2的抗焦虑活性,这种现象被称为“一次试验耐受性”(OTT)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号